📋 Clinical Overview

Dibucaine is a potent, long-acting amide-type local anesthetic used topically for surface anesthesia. The 1.1% w/w concentration is a high-strength formulation primarily intended for temporary relief of pain and itching associated with minor skin conditions, hemorrhoids, and anal fissures.

💊 Dosage & Administration

Adult: Apply a thin layer to the affected area up to 3-4 times daily, or as directed by a physician. The total dose and area of application should be minimized.

Note: For external use only. Clean and dry the affected area before application. Apply a small amount and rub gently. Wash hands before and after use. Do not bandage or wrap the treated area unless advised by a doctor. Do not use in or near the eyes. Discontinue if irritation occurs or if symptoms worsen.

⚠️ Contraindications

Known hypersensitivity to dibucaine, other amide-type local anesthetics (e.g., lidocaine, bupivacaine), or any component of the formulation
Application to large areas of broken, damaged, or infected skin
Application to mucous membranes (except as specifically indicated for perianal use in certain formulations)
Use in infants and young children (due to high risk of systemic absorption and toxicity)

🔬 Mechanism of Action

Dibucaine diffuses across the neuronal plasma membrane and binds to specific receptors on the intracellular portion of voltage-gated sodium channels. This binding stabilizes the channels in their inactivated state, preventing the transient increase in sodium permeability required for the generation and propagation of action potentials. The blockade is use-dependent (more effective on rapidly firing neurons) and reversible. Its high potency and long duration are attributed to high lipid solubility and strong protein binding.

🤕 Side Effects

Localized skin reactions: transient burning, stinging, redness, itching, or rash at the site of application
Allergic contact dermatitis (in sensitive individuals)
With excessive use or application to large areas: systemic absorption leading to CNS effects (dizziness, nervousness, tremors) and cardiovascular effects (hypotension, bradycardia) are rare but serious.

🤰 Special Populations

Pregnancy: Category C: Animal reproduction studies have shown adverse effects, but there are no adequate and well-controlled studies in humans. Use only if the potential benefit justifies the potential risk to the fetus. Should be used sparingly and for the shortest duration necessary, under medical supervision.

Driving: NA

🔄 Drug Interactions

Other Local Anesthetics (e.g., Lidocaine, Benzocaine)	Additive toxic effects (CNS and cardiovascular). Concurrent use on the same area increases risk of systemic toxicity.	Major
Class I Antiarrhythmic Drugs (e.g., Mexiletine, Tocainide)	Additive cardiotoxic and neurotoxic effects due to similar sodium channel blocking activity.	Moderate
Sulfonamides (e.g., Sulfamethoxazole)	Dibucaine is a derivative of 2-alkoxyquinoline-4-carboxylic acid and may theoretically antagonize the antibacterial effect of sulfonamides (PABA antagonist mechanism). Clinical significance is unclear.	Theoretical/Mild

Proctosedyl (Combination)